Philip Skehan

15.2k total citations · 4 hit papers
40 papers, 13.6k citations indexed

About

Philip Skehan is a scholar working on Molecular Biology, Cell Biology and Biomedical Engineering. According to data from OpenAlex, Philip Skehan has authored 40 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cell Biology and 8 papers in Biomedical Engineering. Recurrent topics in Philip Skehan's work include 3D Printing in Biomedical Research (8 papers), Cellular Mechanics and Interactions (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Philip Skehan is often cited by papers focused on 3D Printing in Biomedical Research (8 papers), Cellular Mechanics and Interactions (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Philip Skehan collaborates with scholars based in United States, Canada and Norway. Philip Skehan's co-authors include Anne Monks, Dominic A. Scudiero, David T. Vistica, Susan Kenney, Heidi R. Bokesch, jeannette mcmahon, M. R. Boyd, James T. Warren, Ritsa Storeng and Robert H. Shoemaker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Journal of Cell Science.

In The Last Decade

Philip Skehan

39 papers receiving 13.1k citations

Hit Papers

New Colorimetric Cytotoxicity Assay for Anticancer-Drug S... 1990 2026 2002 2014 1990 1991 1990 1991 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
    1990 8.8k citations Philip Skehan, Ritsa Storeng et al. JNCI Journal of the National Cancer Institute profile →
  2. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines
    1991 2.9k citations Anne Monks, Dominic A. Scudiero et al. JNCI Journal of the National Cancer Institute profile →
  3. Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines
    1990 859 citations Larry Rubinstein, Robert H. Shoemaker et al. JNCI Journal of the National Cancer Institute profile →
  4. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
    1991 629 citations David T. Vistica, Philip Skehan et al. PubMed profile →

Peers

Philip Skehan
David T. Vistica United States
M. R. Boyd United States
Kenneth D. Paull United States
David G. I. Kingston United States
jeannette mcmahon United States
Susan Kenney United States
Ritsa Storeng Norway
Heidi R. Bokesch United States
Monroe E. Wall United States
TOMIO TAKEUCHI Japan
David T. Vistica United States
Philip Skehan
Citations per year, relative to Philip Skehan Philip Skehan (= 1×) peers David T. Vistica

Countries citing papers authored by Philip Skehan

Since Specialization
Citations

This map shows the geographic impact of Philip Skehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Skehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Skehan more than expected).

Fields of papers citing papers by Philip Skehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Skehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Skehan. The network helps show where Philip Skehan may publish in the future.

Co-authorship network of co-authors of Philip Skehan

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Skehan. A scholar is included among the top collaborators of Philip Skehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Skehan. Philip Skehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skehan, Philip. (2000). Dealing with the data deluge in high throughput screening. Journal of Analytical Methods in Chemistry. 22(5). 145–148. 1 indexed citations
2.
Hamel, Ernest, et al.. (1992). Modulation of tubulin-nucleotide interactions by metal ions: Comparison of beryllium with magnesium and initial studies with other cations. Archives of Biochemistry and Biophysics. 295(2). 327–339. 9 indexed citations
3.
4.
Monks, Anne, Dominic A. Scudiero, Philip Skehan, et al.. (1991). Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. JNCI Journal of the National Cancer Institute. 83(11). 757–766. 2889 indexed citations breakdown →
5.
6.
Skehan, Philip, Ritsa Storeng, Dominic A. Scudiero, et al.. (1990). New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. JNCI Journal of the National Cancer Institute. 82(13). 1107–1112. 8784 indexed citations breakdown →
7.
Vistica, David T., et al.. (1990). New Carbon Dioxide-Independent Basal Growth Medium for Culture of Diverse Tumor and Nontumor Cells of Human and Nonhuman Origin. JNCI Journal of the National Cancer Institute. 82(12). 1055–1061. 14 indexed citations
8.
Rubinstein, Larry, Robert H. Shoemaker, Kenneth D. Paull, et al.. (1990). Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines. JNCI Journal of the National Cancer Institute. 82(13). 1113–1117. 859 indexed citations breakdown →
9.
Skehan, Philip. (1988). Control models of cell cycle transit, exit, and arrest. Biochemistry and Cell Biology. 66(6). 467–477. 10 indexed citations
10.
Friedman, Susan, Heidi R. Bokesch, & Philip Skehan. (1987). The regulation of sterol metabolism by cell interactions. Experimental Cell Research. 172(2). 463–473. 5 indexed citations
11.
Skehan, Philip, James Thomas, & Susan Friedman. (1986). Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity. Cell Biology and Toxicology. 2(3). 357–368. 11 indexed citations
12.
Skehan, Philip. (1986). On the normality of growth dynamics of neoplasms in vivo: a data base analysis.. PubMed. 50(4). 496–515. 19 indexed citations
13.
Skehan, Philip & Susan Friedman. (1985). A rapid naphthol yellows method for measuring the cellular protein content of anchorage cultures. In Vitro Cellular & Developmental Biology - Plant. 21(5). 288–290. 11 indexed citations
14.
Friedman, Susan, et al.. (1985). Mechanisms of cholesterol synthesis inhibition by D-glucosamine. Canadian Journal of Biochemistry and Cell Biology. 63(12). 1253–1257. 4 indexed citations
15.
Skehan, Philip & Susan Friedman. (1984). Growth, Cancer, and the Cell Cycle: The Molecular, Cellular, and Developmental Biology. Medical Entomology and Zoology. 2 indexed citations
16.
Skehan, Philip & Susan Friedman. (1982). Deceleratory growth by a rat glial tumor line in culture.. PubMed. 42(5). 1636–40. 12 indexed citations
17.
Friedman, Susan & Philip Skehan. (1980). Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. Proceedings of the National Academy of Sciences. 77(2). 1172–1176. 57 indexed citations
18.
Friedman, Susan & Philip Skehan. (1979). Morphological differentiation of human choriocarcinoma cells induced by methotrexate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(6 Pt 1). 1960–7. 80 indexed citations
19.
Skehan, Philip, et al.. (1979). Cellular senescence and the analysis of generation time distributions. Cell Biology International Reports. 3(6). 535–542. 3 indexed citations
20.
Skehan, Philip. (1975). The mechanisms of glutaraldehyde-fixed sarcoma 180 ascites cell aggregation. The Journal of Membrane Biology. 24(1). 87–106. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David T. Vistica Breakdown of academic impact, for papers by M. R. Boyd Breakdown of academic impact, for papers by Kenneth D. Paull Breakdown of academic impact, for papers by David G. I. Kingston Breakdown of academic impact, for papers by jeannette mcmahon Breakdown of academic impact, for papers by Susan Kenney Breakdown of academic impact, for papers by Ritsa Storeng Breakdown of academic impact, for papers by Heidi R. Bokesch Breakdown of academic impact, for papers by Monroe E. Wall Breakdown of academic impact, for papers by TOMIO TAKEUCHI
Rankless by CCL
2026